Closed
SectorHealthcare
35.25 -1.84
24h
Min
35.01
Max
36.11
Income | 99M 433M |
---|---|
Sales | -26M 568M |
P/E Sector Avg | 14.449 50.291 |
EPS | 1.057 |
Dividend yield | 2.49 |
Profit margin | 76.275 |
EBITDA | 172M 534M |
Recommendations | Strong Buy |
---|---|
12 Months Forecast | +15.85% upside |
Dividend yield Sector Avg | 2.49% 2.40% |
---|---|
Next Earnings | 7 sie 2025 |
Next Dividend date | 12 wrz 2025 |
Next Ex Dividend date | 15 sie 2025 |
Market Cap | 951M 20B |
---|---|
Previous open | 37.09 |
Previous close | 35.25 |
By Acuity
50%
50%
154 / 380 Ranking in Healthcare
By Trading Central
Confidence
Bullish Evidence
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Price change
By TipRanks
12 Months Forecast
Average 41.6 USD 15.85%
High 51 USD
Low 33 USD
Based on 5 Wall Street analysts offering 12 month price targets forRoyalty Pharma PLC (Class A) - Dist in the last 3 months.
By Acuity
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Average
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$